Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare omega-3 fatty acids with placebo for efficacy in
retardation of increase of serum creatinine(SCr) in IgA Nephropathy